Jump to content

Search the Community

Showing results for tags 'Immunization'.

More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


  • Discussions
    • Polio
    • Flu awareness
    • European Immunization Week, 23–29 April 2018
    • Migration and immunization
    • World Hepatitis Day, 28 July 2017
    • European Immunization Week, 24 - 30 April 2017
    • General discussions
    • Education on Immunization
    • Data visualization
    • About NITAGs
    • Research papers, articles, and reports
    • News and social media
    • Updates from partners and stakeholders
    • European Immunization Week (2016)
    • Job opportunities
    • Q&A about the site
    • Innsbruck Treffen (private forum)


  • European Immunization Week 2018
    • Planning resources - EIW 2018
    • Brochures - EIW 2018
    • Infographics - EIW 2018
    • Posters - EIW 2018
    • Banners and social media - EIW 2018
    • Meeting folders - EIW 2018
  • Flu Awareness - 2017
    • Flu Awareness Campaign Posters
  • European Immunization Week 2017
    • Planning resources - EIW 2017
    • Brochures - EIW 2017
    • Infographics - EIW 2017
    • Posters - EIW 2017
    • Banners and social media - EIW 2017
    • Meeting folders - EIW 2017
  • Flu Awareness - 2016
    • Flu Awareness Campaign Posters
  • EIW 2016
    • Planning resources
    • Posters
    • Meeting folders

Find results in...

Find results that contain...

Date Created

  • Start


Last Updated

  • Start


Filter by number of...


  • Start



About Me





Found 39 results

  1. Version 1.0.0


    In preparation for EIW, NCDC translated into Georgian and adapted several WHO/EURO materials including posters, infographics, background information and key messages.
  2. Campaign in Zoo took place at the end of immunization week on 28th of April at Tbilisi Zoo. Animators were invited for organizing entertainment activities for children such as games, competitions in dancing and painting. NCDC with volunteers from Tbilisi State Medical University will distribute all leaflets, balloons with campaign logo and chalks.
  3. On 27th of April working meeting on Measles was conducted with participation of over 50 staff of NCDC, WHO, UNICEF, CDC, regional public health specials and pediatricians to discuss issues on the below mentioned topics: - Measles and Rubella Global and Regional Epidemiological Overview - Analysis of Measles outbreak in Georgia - Immunization Coverage Survey results and recommendations - Results and recommendations of two KAP surveys on immunization conducted among parents (UNICEF funded) and Adults (CDC/WHO funded) - Immunization Management Module challenges and achievements - Responses to current measles outbreak - Measles and Rubella Elimination Plan
  4. Campaign in Policlinic. On 25th of April one of the big primary health care facility (policlinic) “Janmrtelobis Sakhli” involved in immunization program in Tbilisi hosted the campaign. During the campaign information leaflets and gifts such as balloons, mugs, paper notebooks, bags and pen with campaign logo was distributed among parents, their children and HCWs by NCDC and Medical University volunteers.
  5. Measles cases increase significantly in the last month in a number of EU/EEA countries Measles cases continue to increase in a number of EU/EEA countries. The highest number of cases to date in 2018 were in Romania (1 709), Greece (1 463) France (1 346) and Italy (411) respectively. Thirteen deaths have also been reported by these countries in 2018. Although cases in Romania and Greece remain high, of particular concern is the situation in France and Italy, with cases almost tripling in France since the previous update in March, and more than doubling in Italy. This is according to the most recent measles data collected by ECDC through epidemic intelligence and published in the Communicable Diseases Threats Report (CDTR) today. In the 12-month period between 1 March 2017 and 28 February 2018, 14 813 cases of measles were reported to ECDC through the European Surveillance System which is detailed in ECDC’s monthly measles and rubella monitoring report also published today. Of these cases where age was known, 35% were in children under five and 47% were in those 15 and older. Where vaccination status was known, 86% were unvaccinated. In order to reach elimination and protect those most vulnerable to severe complications and death from measles such as infants, 95% of the population needs to be vaccinated with two doses of measles-containing vaccine. Vaccination coverage was below 95% in 22 out of 29 EU/EEA countries for the second dose of a measles-containing vaccine according to the most recent data collected (WHO 2016), showing that further sustained action is needed. The data further showed the high proportion of cases among young adults who may have missed vaccination, highlighting the need for them to check their vaccination status and get vaccinated if needed. Read more The following outputs are available for a complete overview of data regarding measles outbreaks in the EU/EEA Communicable Disease Threat Report - “Measles and Rubella, Monitoring European and worldwide outbreaks” - Epidemic intelligence data Monthly measles and rubella monitoring report - European Surveillance System data (TESSy) Rapid risk assessment: risk of measles transmission in the EU/EEA – TESSy and epidemic intelligence data Bi-annual measles and rubella monitoring report -TESSy and epidemic intelligence data ECDC Atlas of Infectious Diseases -TESSy data ECDC vaccine scheduler
  6. Version 1.0.0


    Herd immunity in PDF (Download button on the right) or in editable AI format (Adobe Illustrator) here: Herd Immunity_WHO_FINAL.ai
  7. Applications are being accepted for internships at the WHO Regional Office for Europe with the Vaccine-preventable Diseases and Immunization programme https://tl-int.vcdp.who.int/careersection/ex/jobdetail.ftl?job=1800022&tz=GMT%2B01%3A00 and the Web Communication team https://tl-int.vcdp.who.int/careersection/ex/jobdetail.ftl?job=1800020&tz=GMT%2B01%3A00 Deadline for submissions is 26 January 2018.
  8. Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations. Since the beginning of 2016, 48 deaths due to measles were reported in the EU. New data published today by ECDC in the Communicable Disease Threat Report (CDTR) show that the highest number of measles cases in 2017 were reported in Romania (7 977), Italy (4 854) and Germany (904). Greece is currently experiencing a measles outbreak, with 690 cases including two deaths, reported since May 2017; most cases were unvaccinated or incompletely vaccinated. The monthly measles and rubella surveillance monitoring report is also published today and provides more in-depth analysis of the situation. The spread of measles across Europe is due to suboptimal vaccination coverage in many EU/EEA countries: of all measles cases reported during the one-year period 1 November 2016‒31 October 2017 with known vaccination status, 87% were not vaccinated. Measles increasingly affects all age groups across Europe and in 2017, 45% of measles cases with known age were aged 15 years or older. Romania, Italy, Germany and Greece were the countries most affected by measles during 2016 and 2017 and each shows different trends: Romania saw a sharp increase in cases from October 2016, and the trend has continued throughout 2017; in Italy, the increasing trend started in January 2017, while in Germany it began in February 2017; Greece has seen a measles outbreak starting in the second half of 2017, with 167 cases reported in October. This data is based on analysis of the cases notified to ECDC and included in the monthly and biannual monitoring reports. The latest available figures on vaccination coverage collected by WHO (2016) show that the vaccination coverage for the first dose of measles was below 95% in 18 of 30 EU/EEA countries; for the second dose of measles, it was below 95% in 20 of 27 EU/EEA countries reporting second dose coverage data. In order to achieve the measles elimination goal, the vaccination coverage rates for children targeted by routine vaccination programmes should increase in a number of countries, as the vaccination coverage of the second dose must be at least 95% to interrupt measles circulation and achieve herd immunity. This is particularly important to protect children below one year of age, who are particularly vulnerable to complications of measles but are too young to have received the first dose of vaccine. Read more ECDC collects measles data on a monthly basis via The European Surveillance System (TESSy). In addition, ECDC monitors measles and rubella epidemiology and outbreaks via epidemic intelligence. For a complete overview of data regarding measles outbreaks in the EU/EEA in 2016 and 2017, the following outputs are available and regularly updated: Communicable Disease Threat Report “Measles and Rubella, Monitoring European and worldwide outbreaks” (Epidemic intelligence data) Monthly measles and rubella monitoring report (a concise report with TESSy data from 1 November 2016 – 31 October 2017) Bi-annual measles and rubella monitoring report (an extensive report, TESSy and epidemic intelligence data presented, with data from 1 January 2016 – 30 June 2017) ECDC Atlas of Infectious Diseases (TESSy data) Monthly-Measles-Rubella-monitoring-report-December-2017_0.pdf
  9. Kyrgyzstan is gearing up for the flu season. Over the past few weeks 100+ healthcare workers across Kyrgyzstan have been trained to store and administer multidose vials of flu vaccine. WHO also facilitated donation of 105,000 doses of the vaccine. For more on the campaign see: http://www.euro.who.int/en/countries/kyrgyzstan/news/news/2017/11/105-000-doses-of-vaccine-flown-into-kyrgyzstan-to-kick-start-influenza-immunization-campaign) Did you know that you can follow the flu season week by week through the joint WHO/ECDC Flu News Europe bulletin? The site gives weekly and seasonal updates, virus characteristics and country data in tables and maps and you can sign up for email alerts: https://flunewseurope.org/
  10. Migration and vaccination: Protecting Syrian refugee children in Turkey “I learned in Syria that vaccinations are important,” says a Syrian refugee mother waiting in the lobby of a clinic in southeastern Turkey. Holding her baby boy, she explains that she is here to have him immunized. “I got the first two rounds of the vaccination at a Turkish hospital and health centre,” says another Syrian mother in her native Arabic. Turkish and Arabic are very different languages and use different alphabets, so Syrian patients and parents can encounter problems understanding when they go to Turkish medical facilities. “It was a little difficult with the language,” she continues. “It’s good that there are Syrian doctors here.” The mothers are at one of Turkey’s clinics for Syrian refugees, staffed by both Turkish doctors and WHO-trained Syrian doctors and nurses who are themselves refugees. Since the brutal conflict in Syria began, 3 million Syrians have poured into neighbouring Turkey. Although the Turkish Ministry of Health has worked hard to provide for their needs, the strain on Turkey’s health system has been immense. In addition, experienced Syrian doctors and nurses had earlier been unable to practice medicine in Turkey due to accreditation issues. With help from WHO, these Syrian health professionals are being screened and then trained to adapt to Turkey’s health care system. When they successfully complete classroom work and six weeks of on-the-job training, they can be employed legally in Turkey’s public clinics and provide care to their fellow refugees. Vaccination is an important part of this care, especially because the conflict caused many Syrian children to miss out on vaccines in their home country. “I remember one child about 3 years old,” says Selam, a Syrian nurse trained as part of the WHO programme. “The parents didn’t want to get the vaccination because of the language barrier.” Refugee children visit a vaccination centre in southeastern Turkey. Photo: WHO/Sheahen “The Turkish government has been encouraging and providing vaccination, but some people didn’t want to,” continues Selam. Immunizing all children in Turkey is urgently important. As the Syrian conflict has decimated vaccination efforts, there have been outbreaks of polio and measles across the border in Syria, just a few hours’ drive away from cities in southeastern Turkey. Now that refugee parents in Turkey can talk to Syrian doctors in their own language at the clinics, there is less confusion and concern. Dr Dalal Kouryani, who escaped Syria with her husband, took the training, which included information on Turkish acronyms for vaccines and the Turkish vaccination schedule. “We like this training because we’re helping Syrians,” she says. The WHO programme also trains bilingual Turkish-Arabic speakers in understanding medical terminology, including words related to immunization. Earlier, “There were lots of translators, but sometimes they can’t bridge the gap, they don’t know the terms,” says Selam. Now, hundreds of WHO-trained Syrian staff have been hired by Turkey’s clinics for refugees. WHO Turkey is also helping to build, equip, and cover operating costs of several refugee health centres where basic primary care, including vaccinations, is free. Arabic-language brochure from Turkey's Ministry of Health about vaccinations for refugee children. WHO also helps Turkey’s Ministry of Health spread the word about vaccination campaigns that specially target refugee children. In 2017, these campaigns reached more than 360 000 refugee children in Turkey to prevent diseases including measles and polio, using the same vaccination schedule used for Turkish children. “With outbreaks of polio and measles in nearby Syria, it’s more important than ever to protect children living in Turkey,” says Dr Pavel Ursu, WHO Representative for WHO Turkey. “The strategy of reaching every child through proper and timely immunization is part of the universal health coverage which the Turkish government offers to all Syrian refugees."
  11. The magnitude of refugee and migration movements in recent years in the Region and complexities associated with the migration phenomenon pose significant public health challenges that necessitate a coordinated response. Taking note of this situation, a technical briefing session on “Immunization and Migration” was organized on 11 September 2017 during the Regional Committee Meeting of the WHO European Region in Budapest, Hungary. The European Vaccine action plan 2015-2020 outlines the need for an equitable access to vaccination of all vulnerable populations including refugees and migrants. The session brought together the Member States, development partners, and other relevant stakeholders to better understand the provision and implementation of immunization services for the refugees and migrants. I joined Mr Robb Butler, Programme Manager Vaccine-Preventable diseases and Immunization (VPI), WHO European Region who co-hosted the session with Dr Santino Severoni from Migration and Health unit of WHO European Region. Listening to the experiences from Germany, Greece, Italy, Sweden and Turkey including the other Member States and partners in the audience on their experiences in providing immunization services to the migrants and refugees was an immense learning for me. Local innovations, coordination between national policy planners and subnational implementers, necessary changes in legislation and regulations, and using local data by the technical advisory groups for decision-making were the key highlights of the discussion. A brief synopsis of the session is available here; http://www.euro.who.int/en/about-us/governance/regional-committee-for-europe/67th-session/news/news/2017/09/day-1-highlights-rc67-opens WHO Europe is developing a Health Evidence Network (HEN) synthesis report which will assimilate the available evidence on equitable delivery, access, and utilization of immunization services for migrants and refugees in the WHO European Region. I will be glad to share the HEN report once it is finalized and available for sharing. What has been your experience regarding the provision of immunization services to the migrants and refugees in your setting? I am keen to expand my knowledge base on this as I hear the first-hand experiences from everyone.
  12. ECDC has published an Expert Opinion on rotavirus vaccination in infancy. The paper provides EU/EEA Member States with relevant scientific information on burden of rotavirus disease, vaccine effectiveness and safety, and cost-effectiveness studies to support the decision-making process on the possible introduction of routine vaccination of children against rotavirus gastroenteritis. Authorised vaccines provide a high level of protection against severe disease in need of medical attention. Evidence suggests that rotavirus vaccination should be initiated before 12 weeks of age and can be administered together with other infant vaccines. The Expert Opinion provides options for monitoring and evaluating the impact of rotavirus vaccination. Read more rotavirus-vaccination-expert opinion-september-2017.pdf
  13. WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) for 2016 are now available on the WHO website: http://www.who.int/immunization/monitoring_surveillance/data/en/
  14. The Confederation of Meningitis Organisations (CoMO) are pleased to share the new: Vaccines Question & Answer Resource! This resource answers many of the more challenging questions surrounding vaccines including the topics of: Vaccine Manufacture and Availability Vaccine Protection Vaccine Safety View online>> Download PDF>> Please share this resource as far and wide as you consider appropriate within your professional and personal networks alike. Use the link: http://bit.ly/VaxQandA and the hashtag: #VaccinesWork CoMO's Vaccines Q&A Resource.pdf
  15. until
    Cognizance Scientific warmly welcomes all participants across the globe to attend Global Congress on Vaccine and Vaccination Techniques is going to be held at Dubai, during April 16-18,2018. Vaccine congress is mainly focused on “Vaccines research and Advance approach towards vaccination techniques for global cause” and its agenda is to produce high quality current research and best practices highlighted keynote presentations, oral and posters abstracts. Vaccine congress gathers diverse disciplines involved in the research and development of vaccines and associated technologies for disease control through immunization. This global platform brings experts, Scientists, research scholars, academic and industry professionals to explore their work and enhance their skills for the improvement of our Scientific Community. Cognizance Scientific also provides an international exposure for young researchers and scholars through their research work by meeting expertise within the field of vaccines and enhancing their knowledge. The Conference comprises with symposium, workshops, Exhibitions, Young research forum, Poster sessions, renowned speakers and eminent keynote presentations. The global vaccines market is expected to grasp USD 48.03 Billion by 2021 from USD 32.24 Billion in 2017 at a CAGR of 8.3% from 2017 to 2021. The major factor driving the growth of this market are high prevalence of diseases, rising government and nongovernment funding for vaccine development, increasing investments by companies, and increasing focus on immunization programs Vaccine 2018 Brochure.pdf
  16. The European Medicines Agency supports the European Immunization Week 2017. As part of our Annual Report 2016 to be published in May this year, a doctor, a researcher and a regulatory body’s representative shared their thoughts on vaccine hesitancy.
  17. Enjoy this picture of a proud team of immunizers! Charles
  18. Unlike most other vaccinations, the one for influenza needs to be take every year in order for it to be effective. This infographic answers the question Why? It talks about antigens and receptors so isn't pitching itself to the 5-sec-glance audience but to those with the curiosity (and need) to understand why this is the case. Would you be interested in translating or adapting it for your own use?We have adaptable files (Adobe Illustrator) available for exactly that purpose.Contact Health.Communication@ecdc.europa.eu to get those files or to find out more.

    © European Centre for Disease Prevention and Control, 2016

  19. Reaching and maintaining sufficiently high immunization coverage is not possible without the active support of health professionals. Unfortunately, many involved in vaccination are not sufficiently informed and may have doubts themselves about the safety or efficacy of the vaccines they are administering. To close this information gap, WHO and the European Society of Paediatric Infectious Diseases (ESPID) developed the Wiser Immunisers online course, which is now offered through the ESPID website. The course is set to begin for the third time on 17 October, and registration is open until 10 October. Course participants earn 12 EU CME credits, and their feedback following the first two runs of the course has been very positive. The ESPID online course on vaccination provides internet-based training on: vaccine-preventable diseases including clinical presentation, diagnosis, management, treatment, prognosis and public health implications vaccines and their side effects and contraindications communicating with patients and caregivers about vaccination, including addressing common misconceptions and tackling vaccine hesitancy. More information about the course and how to register is available on the ESPID website: http://www.espid.org/content.aspx?Group=education&Page=wiser immuniser online course Please pass this information on to individuals or groups who could benefit from learning or refreshing their knowledge about this important topic.
  20. The Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) of the European Commission has recently published a call for tender concerning 2 studies: a study on the added value of the strategic and life-course approach to vaccination and a study on shortcomings related to low vaccination coverage in health care workers. These studies are intended to inform on-going explorations regarding the Commission´s future vaccination policy referred to the background of the Council conclusions on vaccinations, as an effective tool in public health. Deadline is 16 September and all relevant information can be found on CHAFEA’s website These studies are intended to inform on-going explorations regarding the Commission´s future vaccination policy referred to the background of the Council conclusions on vaccinations, as an effective tool in public health http://ec.europa.eu/chafea/health/tender-51-2015_en.html
  • Create New...